Best Lipids Conferences 2018 |Biochemistry Conferences |Lipid Metabolism Conference|Â European Lipids Events | USA | Asia

Theme: Incipient Encroachments in the Field of Lipidology

Lipids 2018

Lipids 2018_Tentative Program

Lipids 2018

After successful completion of 3^rd International Conference on Lipid Science and Technology, we now welcome you to the most exciting event on Lipids to Valencia, Spain.

Title: 4^th International Conference on Lipid Science and Technology
Date : November 01-02, 2018
Venue : Valencia, Spain.
Accreditation: CME and CPD Credits

Theme: Incipient encroachments in the field of Lipidology

The main focus of the conference is recent encroachments and innovative approaches that can enforce Lipid science and Technology, one step further. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.

Lipids Conference 2018 will be organized by ConferenceSeries llc Ltd organises 1000+ Global Events every year on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Importance and Scope:

Lipids, a significant cog of living cells are chemically distinct as an ingredient that is insoluble in water and soluble in alcohol, ether, and chloroform. Along with carbohydrates and proteins, lipids are the chief elements of plant and animal cells. Cholesterol and triglycerides are lipids. Lipids are easily stored in the body. They serve as a source of fuel and are a vital integral of the construction of cells. Lipids include fatty acids, neutral fats, waxes and steroids (like cortisone). Compound lipids (lipids complexed with another type of chemical compound) include the lipoproteins, glycolipids and phospholipids.

Lipid deviations from the mean are related with a prolonged threat for vascular ailment, predominantly heart attacks and strokes. Abnormalities in lipid concern a mix of genetic predisposition and in addition the way of nutritional admission. Several lipid problems are associated with being weighty. Lipid concern might equally connected with altered illnesses including diabetes. There is assembly evidence that administration of cholesterol and triglyceride matter is associated with the diminished danger for heart attacks and strokes.

Today 66% of grown-ups and about 33% of youngsters battle with overweight and obesity. If robustness rates stay reliable, by 2030, 51% of the inhabitants will be obese. Twenty years prior, no state had a stoutness rate above 15%. Today there are 41 states with stoutness rates more than 25%, as indicated by the Trust for Europe’s Health. Following 1980, the rate of weight in kids and young people has practically tripled. 72% of more established men and 67% of more seasoned ladies are currently overweight or stout. Stoutness is connected to more than 60 perpetual illnesses. By European Association for the Study of Obesity, 482,000 Europeans kick the bucket of tumor every year, around 33% of these growth passings are connected to amassing body weight, poor nourishment and/or physical inactivity. More than 75 per cent of hypertension cases are specifically connected to stoutness. Roughly 66% of Europe grown-ups with sort 2 diabetes are overweight or have sturdiness.

Why Valencia??

Valencia is a city and port in Spain on the Costa Blanca, the capital of the region of Valencia and of the comarca of Valencia in the south of the Valencian People group. It is additionally a noteworthy Mediterranean port. The number of inhabitants in the city of Valencia roughly was 334,329, assessed starting at 2014, and positioning as the second-biggest Valencian city. Valencia was one of the quickest developing urban areas in Spain. The blast depended halfway on tourism coordinated to the shorelines of the Costa Blanca and especially on the second living arrangement development blast.

The general economy of the city of Valencia is arranged mostly in the program part, which connected 85.7% of the staff in the year 2007.A dozen Financial activities in Valencia did a great exchange, which customarily had the port grasp. The business exercises with the city have superb energy of bid for the greater part of the state came to by the hub related with Vinalopó to Almansa. Right now, town of Valencia positions fifth broadly in importance as far as exchange can be included, just outperformed basically by urban areas, for example, the town, Barcelona, Valencia and Seville. Alicante is home to a work area for Harmonization in the Inward Market (OHIM), European Organization for the enrollment seeing trademarks and in addition Group outlines. The real College of Alicante, in San Vicente del Raspeig, has more prominent than 33,000 understudies and pulls in an essential number of remote undergrads. The business utilizes A few.7% of the populace from the region. Features contain aluminum manufacturing plants related with snuff, Tabacalera industrial facility was for most hundreds of years of awesome monetary significance inside city.

Session Tracks:

Lipids Conference would like to take this magnificent occasion to welcome everyone interested in Lipid Science to “4^th International Conference on Lipid Science and Technology” that is scheduled at Valencia, Spain during November 01-02, 2018.

The theme of the conference is “Incipient encroachments in the field of Lipidology”.

The 4^thInternational Conference Lipid Science and Technology during November 01-02, 2018 in Spain’s most populous city Valencia. The conference centres on leading issues such as Lipids in Molecular Medicine, Lipid and Lipoprotein Metabolism, Protein-Lipid & Lipid- Lipid Interactions, Obesity and Health, Lipids in Signaling and Intracellular Trafficking, Lipids and Bioenergy, Fats - Cardio Metabolic Risks, Fats - Cardio Metabolic Risks, Lipids: Nutrition and Health, Techniques Involved in Lipid Research, Structural Diversity of Lipids, Lipids in Atherosclerosis, Plant, Microbial Lipids and Essential Oils, Lipids in Plant Research, Lipidomics - What’s Next?, Clinical Lipidology.

Track 1: Lipids in Molecular Medicine

Clinical medicines that associate with membrane lipids and which amend the configuration and building of cell membranes can convert the localization and/or action of membrane proteins. Adjustments in membrane lipid construction are matched in variations in membrane lipid action. Numerous drugs used to combat against cancer, cardiovascular diseases and portliness and other pathologies, regulate lipid structure in plasma membrane and they yield an associated modification in the localization and activity of signaling proteins. Recent studies have stemmed in recognising specific disease-provoking gene mutations and have led to improved clinical and laboratory managements, prenatal diagnosis in lipid linked diseases.

The Injectable Drug Delivery Market by Formulation (Liposomes, Nanoparticles and Microspheres), Devices and Therapeutics [Diabetes and Oncology] - Global Forecasts to 2017, dissects and contemplates the real market drivers, restrictions, and chances in North America, Europe, Asia-Pacific, and Rest of the World. Worldwide injectable medication conveyance advancements market over the gauge time of 2012 to 2017.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

3^rd International Conference on Enzymology and Molecular Biology Conference March 05-06 2018 London UK | 11^th International Conference on Childhood Obesity and Conference on Nutrition March 15-16, 2018 Barcelona, Spain | 3^rd International Conference on Metabolomics and Bariatric Surgery Conference March 15-16, 2018 Barcelona, Spain | 15^th International Conference on Clinical Nutrition May 24-26, 2018, Vienna, Austria | 20^th International Conferences on Obesity May 14-15, 2018, London, United Kingdom | 13^th International Conference on Metabolomics and Systems Biology Conferences June 11-12, 2018 London, UK | 4^th International Conference on Lipid Science & Technology November 01-02, 2018 Valencia, Spain | Experimental techniques for studying proteins and conferences on lipids in biological membranes 31 July - 01 August 2018 Aston University, UK | EMBO Workshop - Enzymes, Biocatalysts and Chemical Biology Conference September 09-12, 2018 Pavia, Italy | 4^thWorld Glycobiology Conferences, September 17-19, 2018 Rome, Italy | 22^nd European Nutritional Science Congress Nov 26-27, 2018 Barcelona, Spain | Conference on Food Antioxidants and Functional Ingredients 7-8 March 2018, London, UK | 2^nd International Symposium on Lipid Oxidation and Antioxidants 4-6 June 2018, Graz, Austria | 16^th Euro Fed Lipid Congress and Expo 16-19 September 2018, Belfast, UK | DGF Jahrestagung 2018 29-30 November 2018, Hamburg, Germany | 7^th European Workshop on Lipid Mediators (7EWLM), Université Catholique de Louvain, Brussels, Belgium 12-14 September 2018 |Conference on Fats, Oils and Lipids: Science, technology and Nutrition Conference in a Changing World, Belfast, UK 16-19 September 2018 | ICLCM 2018: 20^th International Conference on lipid Chemistry and Metabolism London, UK Feb 15-16, 2018 | 2^nd International symposium on Lipid Oxidation and Antioxidants, 4-6 June 2018 Graz, Austria

Related Association:

Europe:

Polish Lipid Association, Hellenic Atherosclerosis Society, British Dietetic Association, Diabetes UK, European Association for the Study of Diabetes, International Federation for the Surgery of Obesity and Metabolic Disorders, German Atherosclerosis Society, Italian Society for the Study of Atherosclerosis (SISA), Austrian Diabetes Society, Croatian Association Diabetes, European Association for the Study of Diabetes

America:

American Oil Chemists' Society, Canadian Cardiovascular Society, American Society for Nutrition, Biophysical Society, American Society for Biochemistry and Molecular Biology (ASBMB), American Skin Association, American Diabetes Association, Canadian Obesity Network, Diabetes Canada, American Society for Metabolism and bariatric Surgery, International Atherosclerosis Society, British Dietetic Association, Diabetes Association of Jamaica,

Asia:

Lipid Association of India (LAI), The Korean Society of Cardiology, Philippine Lipid & Atherosclerosis Society, The Korean Society of Cardiology, Diabetic Foot Society of India, The Diabetes Association of the Republic of China (Taiwan), The Endocrine Society of the Republic of China (Taiwan), Chinese Taipei Diabetes Association, Korean Diabetes Association, The Japan Diabetes Society, Korean Endocrine Society, The Turkish Biochemical society

Track 2: Lipid and Lipoprotein Metabolism

The Activity of Lipoprotein metabolism takes place in two ways via exogenous and endogenous, bases on the origin dietary or hepatic.

Mainstream of dietary lipids are triglycerides (>95%), while the others are phospholipids, free fatty acids, cholesterol and fat-soluble vitamins. The digested triglycerides from the diet form monoglycerides and free fatty acids by several processes, including gastric lipase, bile emulsification and pancreatic lipase. Likewise, cholesterol esters undertake a process of de-esterification to form free cholesterol.

Chylomicrons play a vital role in transport of dietary triglycerides and cholesterol from the enterocytes and into the circulation system. Majority of the triglycerides can be converted to fatty acids and glycerol in the adipose and muscle tissue to provide a source of energy. Exhausted of energy, the chylomicron fragments opulent in cholesterol travel back to the liver to be cleared from the body, through a progression facilitated by apoprotein E.

Lipoproteins can be produced endogenously in the liver with endogenous triglycerides and cholesterol in the hepatocytes, which are from chylomicron remnants. The LDL flows in the bloodstream and can be captivated by cells in the liver or peripheral tissues. The particles can fix to the target tissue with the LDL receptor with the engrossment of apolipoprotein B-100 which can then be engrossed by endocytosis, and the units hydrolyzed to discharge lipids such as cholesterol.

Relevant Lipids Conference | Biochemistry Conferences

Relevant Conferences:

4^th International Conference on Lipid Science & Technology November 01-02, 2018 Valencia, Spain | Experimental techniques for studying proteins and conferences on lipids in biological membranes 31 July - 01 August 2018 Aston University, UK | EMBO Workshop - Enzymes, Biocatalysts and Chemical Biology Conference September 09-12, 2018 Pavia, Italy | 4^thWorld Glycobiology Conferences, September 17-19, 2018 Rome, Italy | 22^nd European Nutritional Science Congress Nov 26-27, 2018 Barcelona, Spain | Conference on Food Antioxidants and Functional Ingredients 7-8 March 2018, London, UK | 2^nd International Symposium on Lipid Oxidation and Antioxidants 4-6 June 2018, Graz, Austria | 16^th Euro Fed Lipid Congress and Expo 16-19 September 2018, Belfast, UK | DGF Jahrestagung 2018 29-30 November 2018, Hamburg, Germany | 27th European Diabetes Congress June 20-21, 2018 Rome, Italy | 21st European Nutrition and Dietetics Conference June 11-13, 2018 Dublin, Ireland | 14th Euro Obesity conference and Endocrinology Congress September 13-14, 2018 London, UK | 11th International Conference on Childhood Obesity and Nutrition Conference March 15-16, 2018 Barcelona, Spain | 4th Glycobiology World Congress September 17-19, 2018 Rome, Italy | Conference on Fats, Oils and Lipids: Science, technology and Nutrition Conference in a Changing World, Belfast, UK 16-19 September 2018 | ICLCM 2018: 20^th International Conference on lipid Chemistry and Metabolism London, UK Feb 15-16, 2018 | 2^nd International symposium on Lipid Oxidation and Antioxidants, 4-6 June 2018 Graz, Austria | 16^th Euro Fed Lipid Congress and Expo 16-19 September 2018, Belfast, UK | DGF Jahrestagung 2018 29-30 November 2018, Hamburg, Germany | 7^th European Workshop on Lipid Mediators (7EWLM), Université Catholique de Louvain, Brussels, Belgium 12-14 September 2018

Related Association:

Europe:

Diabetes UK, European Association for the Study of Diabetes, International Federation for the Surgery of Obesity and Metabolic Disorders, Polish Lipid Association, Hellenic Atherosclerosis Society, British Dietetic Association, Croatian Association Diabetes, European Association for the Study of Diabetes, German Atherosclerosis Society, Italian Society for the Study of Atherosclerosis (SISA), Austrian Diabetes Society

America:

International Atherosclerosis Society, British Dietetic Association, Diabetes Association of Jamaica, American Skin Association, American Diabetes Association, Canadian Obesity Network, Diabetes Canada, American Society for Metabolism and bariatric Surgery, American Oil Chemists' Society, Canadian Cardiovascular Society, American Society for Nutrition, Biophysical Society, American Society for Biochemistry and Molecular Biology (ASBMB)

Asia:
Chinese Taipei Diabetes Association, Korean Diabetes Association, The Japan Diabetes Society, Korean Endocrine Society, The Turkish Biochemical society, Lipid Association of India (LAI), The Korean Society of Cardiology, Philippine Lipid & Atherosclerosis Society, The Korean Society of Cardiology, Diabetic Foot Society of India, The Diabetes Association of the Republic of China (Taiwan), The Endocrine Society of the Republic of China (Taiwan)

Track 3: Protein-Lipid & Lipid- Lipid Interactions

Single lipid element will stay in the annular shell round a protein for a momentary timeframe. Tying to the annular shell indicates generally minimal auxiliary specificity. And the annular lipid, there is proof for other lipid atoms bound between the transmembrane alpha-helices of the protein; these lipids are alluded to as non-annular lipids. Voltage-gated channels are key transducers of film potential changes into intracellular homeless people that start numerous physiological occasions. The conformational change mutilates the state of the channel proteins adequately such that the depression, or channel, opens to concede particle flood or efflux to happen over the layer, down its electrochemical angle.

Lipid microarrays will give an incorporated learning base to the human lipidome. Exogenous fat is transported in chylomicrons from the digestive system to the liver. After passage in the circulatory system the chylomicrons are hydrolyzed by the endothelial-enslaved lipoprotein lipase. The chylomicron leftovers are quickly taken up into the liver by means of the LDL receptor and the LDL receptor-linked protein. Apolipoprotein E and lipoprotein lipase are the acknowledgment signals for these receptors. The liver uses the exogenous fat and can discharge surplus lipids by means of VLDL into the blood. The remaining VLDL leftovers can either be taken up into the liver or are hydrolyzed to LDL. Both these types of Hypercholesterolemia are the most successive and speak to significant danger elements for arteriosclerosis.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 4: Obesity and Health

Surveys of 2009-2010 by NHANES explains, roughly 69% of adults are obese, with more than 78 million adult Americans painstaking obese.

Obesity is not unbiased a superficial problem but is a health threat. Person who is 40% bulky is twice as expected to die early compared to a normal person. Ailments like Diabetes, High BP, Cancer, Heart disease and stroke, Gallbladder disease and gallstones, Gout, Breathing problems like sleep apnea and asthma and Osteoarthritis are the consequences of Obesity.

Obesity is the consequence of many factors functioning together such as the choices you sort, your metabolism, environment and genes in your body. Currently 66% of grown-ups and about 33% of youngsters battle with overweight and obesity. If heftiness rates stay reliable, by 2030, 51 percent of the populace will be obese. Today there are 41 states with stoutness rates more than 25 percent, as indicated by the Trust for Europe’s Health.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 5: Lipids in Signaling and Intracellular Trafficking

Lipid signaling and intracellular trafficking gives to innovative methodologies in the management of a number of hematologic and other ailments. NIH has invested $127,980 in this specific area in 2015.

Lipid rafts/caveolae flagon designed constructions are opulent in proteins and furthermore lipids example: cholesterol and sphingolipids and have a rare volumes in signal transduction. They assume a part in disease cells advancement, endocytosis and the uptake of pathogenic microorganisms and certain infections. Ponders that have illustrated the part of lipid pontoons in flagging by means of bioreceptor tyrosine kinases and G protein-coupled receptors. The inositol phospholipids frame the basic premise for a mind boggling interchange of flagging reactions created, most regularly, by receptor actuation and bringing about changes in Ca +2 , protein kinase falls, and particle channel/exchanger movement. Phosphatidylinositol (PI) itself is a negligible phospholipid constituent of all eukaryote plasma films.

In spite of the statement that the plasma layer might comprise microdomains with an variety of several lipid creations, cholesterol and sphingolipid rich microdomains, named lipid flatboats, have been the most strongly examined. Flatboats are hypothesized to direct protein–protein interactions by horizontally isolating proteins as per their partiality for requested layer areas. New endeavours need to create and test elective theories for lipid-intervened natural capacity are basic to propelling our comprehension of plasma layer areas and their parts in cell capacity. Cholesterol is an amphipathic particle like phospholipid moiety. It contains a hydrophobic interactions and hydrophilic interactions. Regardless of its little mass, cholesterol assumes a critical part in keeping up the trustworthiness of the film and is likewise included with cell to cell flagging procedure.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 6: Lipids and Bioenergy

Advancements in science and technology transforms biomass, as well as wastes, into Bioenergy comprising fuels, and fuel additives.

Fossil fuels are the lifeblood of our society and for many others around the world. The environmental pollution due to the use of fossil fuels as well as their gradual depletion make it necessary to find alternative energy and chemical sources that are environmentally friendly and renewable. Waste lipids are ideal potential substrates for biogas production, since theoretically more methane can be produced, when compared with proteins or carbohydrates. Anaerobic bioconversion of complex organic matter to methane consists of a series of microbiological processes. First step involves the hydrolysis of complex organic polymers (proteins, carbohydrates and lipids) into monomers by extracellular enzymes that are excreted by fermentative bacteria. Proteins are degraded to amino acids, carbohydrates to soluble sugars and lipids to glycerol and LCFAs by the concerted action of proteases, cellulases and lipases respectively. Lipid hydrolysis is generally faster than protein or carbohydrate hydrolysis, and considered to be a rapid process in anaerobic digestion.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 7: Fats - Cardio Metabolic Risks

The monetary load of lipid condition is considerable due to the impact of lipid altitudes on the risk of cardiovascular disease and coronary heart disease trials. The nature of fat is for the most part indicated by the relative substance of SFA, monounsaturated (MUFA), and polyunsaturated unsaturated fats (PUFA) including the extent or measure of vital unsaturated fats, that is, linoleic corrosive (LA) and α-linolenic corrosive (ALA), as well as the extent or measure of long-chain n-3 unsaturated fats (n-3 LCPUFA), that is, eicosapentaenoic corrosive (EPA) and docosahexaenoic corrosive (DHA). Coronary illness is perceived to be the reason for death for 80% of individuals with diabetes.

Diabetes is treatable, however notwithstanding when glucose levels are under control it incredibly expands the danger of coronary illness and stroke. Hypertension has for quite some time been perceived as a noteworthy danger component for cardiovascular illness. Weight is a noteworthy danger element for cardiovascular disease and has been unequivocally connected with insulin resistance. Physical idleness is another modifiable real hazard component for insulin resistance and cardiovascular infection. Fish, plant, and nut oils are the essential dietary origin of omega-3 unsaturated fats. Eicosapentaenoic corrosive (EPA) and docosahexaenoic corrosive (DHA) are found in icy water fish, for example, salmon, mackerel, halibut, sardines, fish, and herring. Dietary admission of omega-3 unsaturated fats has declined by 80% amid the most recent 100 years, while admission of omega-6 unsaturated fats has extraordinarily expanded. Omega-3 unsaturated fats are cardioprotective for the most part because of helpful impacts on arrhythmias, atherosclerosis, irritation, and thrombosis.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 8: Lipids: Nutrition and Health

Lipids play a vital role in nutrition science, lead to new concepts with novel discoveries. Present track analyses the part of dietary lipids in sustaining health, fetching the up-to-date awareness from a countless of bases into one useful means. The joint methodology which incorporates lipid nutrition with standard physiology and clinical presentations.

The biochemistry and sources of lipid compounds, followed by coverage of lipid requirements for a healthy state. Organized by lipid category, the text describes the role played by each lipid in various chronic diseases. It examines specific macronutrients and micronutrients, emphasizing their absorption, metabolism, and deficiency symptoms with respect to their roles in cardiovascular disease, cancer, metabolic diseases, inflammatory diseases, and various pathologies of the nervous system.

Offering a broad overview of all aspects of lipids, from the fatty acids to the other forms of fats, the book provides an extensive and up-to-date survey of the impact of dietary lipids on several phases of pathological conditions. It provides the information needed to efficiently translate new research findings and clinical experiences into practical and personalized recommendations for preventing diseases and treating pathologies induced by poor dietary conditions.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 9: Techniques Involved in Lipid Research

As lipids are soluble in organic solvents that offer food analysts with an appropriate method of separating the lipid components in foods from water soluble components like proteins, carbohydrates and minerals. Solvent extraction procedures are one of the most frequently used procedures of isolating lipids from foods and of determining the total lipid content of foods.

These techniques like classical Bligh & Dyer lipid extraction, chemical extractions by means of diverse solvents and sonication, direct saponification and supercritical CO2 extraction used to extract cellular or liquefied lipids from the other components like proteins, polysaccharides, small molecules (amino acids, sugars...) and use them for advanced investigations.

There are varied methodologies as biological tissues are not alike when considering their structure, texture, sensitivities and lipid contents. The ideology behind the solvent extraction is to completely extract all the lipid components from a sample, leaving the other components behind which always depends on the polarity of the lipids present.

These techniques require the use of very pure solvents and clean glassware. Soxhlet-based extraction was used to evaluate the significance of solvent polarity in the algal oil extraction.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 10: Structural Diversity of Lipids

Lipids plays vital role in Biology. Triglycerides digestion yields glycerol and fatty acids, which consequently used as energy. The other l living utilities embrace: cell membrane construction, energy storage, and as signaling molecules. Lipids can build links to proteins and carbohydrates establishing lipoproteins and lipopolysaccharides.

Multiple roles can be performed by Phospholipids in cells by creating the permeability blockade for cells and cell organelles and by providing the matrix for the association and utility of a wide diversity of catalytic developments, also by substitute as donors in the production of macromolecules, and by keenly inducing the functional properties of membrane-associated developments.

Lipids are a different and ubiquitous cluster of compounds having key biological functions like structural constituents of cell membranes, aiding as energy storage bases and play a part in cell signaling pathways. Compound research in structural diversity of lipids benefits developments in the field of membrane lipids which in turn explains biological phenomena at the nanoscale sphere.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 11: Lipids in Atherosclerosis

Lipid anomalies play a vital role in the improvement of atherosclerosis. Primary trials in animals revealed faster atherosclerosis with a high-cholesterol diet. This was surveyed by epidemiologic analyses conducted in countries around the world that indicated a cumulative occurrence of atherosclerosis when serum cholesterol concentrations were raised up.

Extensive investigations in cardiovascular diseases (CVD) revealed the lipid mechanisms, and pathways leading to the arterial atherosclerosis.

Atherosclerosis is the leading cause of death in North America and within the next two decades will be the leading cause worldwide. Atherosclerosis is characterized by vascular obstruction from the deposits of plaque, resulting in reduced blood flow. Plaque rupture and the consequent thrombosis may lead to sudden blockage of the arteries and cause heart attack. High serum lipid levels, especially the elevated level of low-density lipoproteins (LDL), have been shown to be strongly related to the development of atherosclerosis. It is generally accepted that atherosclerotic lesions are initiated via an enhancement of LDL uptake by monocytes and macrophages. In the liver, uptake of plasma LDL is mediated via specific LDL receptors, but a scavenger receptor system is employed by macrophages. Plasma LDL must be modified prior to uptake by macrophages.

The role of oxidized lipids in cardiovascular diseases (CVD) has been investigated over the last three decades extensively. A number of studies have been carried out on the mechanisms, and pathways leading to the arterial atherosclerosis.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 12: Plant, Microbial Lipids and Essential Oils

Lipids being insoluble in water; thus, play a vital part of the main structural elements of protoplasm. Lipids and lipid–protein complexes responsible for the construction of superficial membranes of cells and cell organs include nucleus, mitochondria, and ribosomes. Lipids join in the progression of active transportation of ions and molecules via membranes. Sources of energy are neutral lipids.

Terpenes are the components of essential oils, which diverge from fatty oils as they do not have glycerides of fatty acids. Several essential oils comprise saturated and unsaturated aliphatic, aromatic, terpene, sesquiterpene, mono and bicyclic hydrocarbons, and the oxygen derivatives like aldehydes, alcohols, esters, ketones, lactones, ethers of acids, and oxides also heterocyclic compounds.

Lipids, lipophilic constituents and essential oils are extensively used in the food industry, engineering, pharmacy, perfumery and cosmetics, for the manufacture of lacquers and colours. Essential oils are situated in the flowers and leaves of plants and citrus fruits. Further in plants, lipids are most frequently concentrated in the seeds and fruits.

Lipid Peroxidation by an unmistakable bit of UV light prompts an adjustment of the plant lipids. This alteration concentrates them solid inducers of heme oxygenase expression and mixture of glutathione, the most significant cellular cell fortification. Initiated lipid separates from plants prompt inborn cancer prevention agent and detoxificationpathways of skin cells. Furthermost strong individuals can eat ALA from plant springs like chia and flaxseeds which will be transformed into EPA and DHA. Just seven to 15 percent of the dietary ALA might be changed over to EPA. Considerably less is changed over to DHA. Furthermore, this is in a sound youngster. Soybean, canola, wheat germ and walnut oil all have a nice measure of omega-3's, yet much larger amounts of omega-6 unsaturated fats - and this proportion of omega-3's to omega-6's is imperative. Wellbeing specialists suggest an omega-6/omega-3 proportion of around 4:1.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 13: Lipids in Plant Research

The sites of stimulus sensitivity and signal transduction are Cell membranes. Lipids of membrane are ironic homes for the manufacture of signaling messengers which facilitate plant progress, growth, and reaction to nutrient status and strains. Substantial progress has been made now a day toward understanding lipid signaling in plants, but many questioned remained unsolved. Some of the questions like what lipids are signaling messengers or intermediaries in plants? In what part of the plant several lipid mediators involved? How signaling functions work out and how the signaling lipids manufactured and digested? How the lipid signaling networks add to modulate plant development, progress, and reacts to hormones and strains?

Interpretation of LD-linked proteins, for example, oleosins, caleosins, and sterol dehydrogenases (steroleosins), has uncovered astonishing components of LD capacity in plants, including cell stress reactions, hormone flagging pathways, and different parts of plant development and improvement. Proteins like oleosin and caleosin are definite to plants, LD-related sterol dehydrogenases similarly are presented in well evolved creatures, and in both plants and warm blooded animals these compounds have been performed to be imperative in (steroid) hormone digestion system and flagging. Few proteins which are not vital in LD biogenesis in yeasts and vertebrates are conserved in plants, endorsing that in any event a few parts of LD biogenesis and/or capacity are developmentally monitored.

Lipids are stored in the form of triglycerides in plants. For examples higher plants. Plants like desert shrub, jojoba that stores lipid as a liquid wax. Lipids storage may be confined to seed tissue, embryo or endosperm whereas in oilseeds like sunflower, linseed or rapeseed, the cotyledons of the embryo are the major sites of lipid gathering. Species such as castor bean, coriander or carrot, the endosperm is the chief spot of lipid storage.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Track 14: Lipidomics - What’s Next?

A nascent field of biomedical research is Lipidomics that is dealt with lipidome analysis. The broad and quantitative explanation of Lipid classes in an organism is called Lipidome. Lipidomics implicates systems-level credentials and quantitation of thousands of alleyways and set-ups of cellular lipids molecular species and their relations with other lipids, proteins and other moieties in vivo.

Biological functions of lipids include Cell signaling, energy storage, structural components of cell membranes, endocrine functions, signal transduction, membrane trafficking and morphogenesis.

Latest technology is used in Lipidomics to recognize, measure, and comprehend the construction and utility of lipids in biological systems.

Techniques include: mass spectrometry, fluorescence spectroscopy, nuclear magnetic resonance, microfluidic devices and column chromatography.

Identifying the lipid construction by mass spectrometry is complex due to varied lipid species and lipid molecular traits. Using the same method for all lipid classes for extraction, chromatography and detection is difficult. Lipidomics research is quite challenging, exciting, and unique because of the complexity and specificity. Conflicting to genomics and proteomics, there is no evidence that can forecast the number of individual lipid molecules present in an organism.

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Track 15: Clinical Lipidology

Most rapidly developing field is Clinical Lipidology which will aid bring up to date those involved in all aspects of this field. This covers a broad cross-section of the medical communities like cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity.

Advancements in the statin therapies, Clinical Lipidology goals to deliver an opportunity for novel clinical conclusions, therapeutic impressions of optimal management approaches and interpretation on upcoming trends, counting mixture of approaches, as well as cutting edge translational investigation, and will provide the progressively time-constrained scientific community with an accessible and absolute source covering all features of lipids in health and ailment. Significant improvements in the field are conveyed and analyzed by international professionals, providing an authoritative, but manageable, forum for this progressively chief area of exploration.

Obesity and the metabolic syndrome

Related cardiovascular diseases, such as atherosclerosis

Treatment of lipid-related disorders

Cost-effectiveness of therapeutics

Research in emerging areas such as the use of liposomes for drug delivery and gene therapy

Summaries of newly approved therapeutic agents

Side effects of lipid-lowering medication

Dietary prevention

Results of recent clinical trials relevant to the field of lipidology

Diagnostic and clinical criteria

Preventive medicine

Lipids Conference | Biochemistry Conferences

Relevant Conferences:

Related Association:

Europe:

America:

Asia:

Market Analysis:

Importance and Scope:

The abnormalities of lipids such as cholesterol and triglycerides are associated with an increased risk for vascular disease, and especially heart attacks and strokes. Abnormalities in lipid disorders are a combination of genetic predisposition as well as the nature of dietary intake. Many lipid disorders are associated with being overweight. Lipid disorders may also be associated with other diseases including diabetes, the metabolic syndrome (sometimes called the insulin resistance syndrome). There is accumulating evidence that management of cholesterol and triglyceride disorders is associated with the reduced risk for heart attacks and strokes. This is especially true in patients seen by endocrinologists who have diabetes mellitus or other problems associated with obesity.

Elevated total cholesterol is most commonly a problem in patients who have elevated LDL cholesterol levels. Moderate elevations of LDL cholesterol are more common. These moderate elevations are still associated with heart disease risk. There are well established standards for what the targets of LDL cholesterol should be based on risk adjustment profiles. For example, young people with no heart disease risk factors have higher LDL cholesterol targets than patients who have diabetes or established heart disease.

Hypertriglyceridemia is associated with increased heart disease risk. Hypertriglyceridemia is commonly associated with obesity and diabetes mellitus. The medications used for treating triglycerides are often different than those used to lower LDL cholesterol. Treatment of contributors to high triglycerides including reduction in body weight and the management of diabetes mellitus are also important. Some medications used to lower blood sugar will also have a favorable effect on triglycerides. Isolated low cholesterol, low HDL cholesterol is quite uncommon. Most of the time low HDL cholesterol is associated with high triglycerides. It is well known that low HDL cholesterol contributes to heart disease risk. Exercise is important in helping to raise HDL cholesterol.

The metabolic syndrome is a term to describe patients who have central obesity, elevations of blood sugar (including diabetes), elevations in blood pressure as well as a lipid disorder characterized as high triglycerides, low HDL (and often mildly elevated LDL).

Why to attend?

Lipids 2018 could be an exceptional event that brings along a novel and International mixture of giant and medium lipid research analysis, leading universities and Companies establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in the field of lipids science and Novel treatment methods for CVD’s and Obesity are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://lipids.conferenceseries.com/sponsors.php

Major Associations and Hospitals in Europe:

Polish Lipid Association
Hellenic Atherosclerosis Society
British Dietetic Association
Diabetes UK
European Association for the Study of Diabetes
International Federation for the Surgery of Obesity and Metabolic Disorders
German Atherosclerosis Society
Italian Society for the Study of Atherosclerosis (SISA)
Austrian Diabetes Society
Croatian Association Diabetes
Finnish Diabetes Association
Diabetes Ireland
Lithuanian Diabetes Association
The Luxembourg Diabetes Association
Maltese Diabetes Association
Swiss Diabetes Foundation
Swedish Diabetes Association
Association for the Protection of Diabetics of Portugal
Polish Diabetes Association
The Norwegian Diabetes Association
International Diabetes Federation
Estonian Diabetes Association
Society for Endocrinology
International Society of Endocrinology
European Atherosclerosis Society
European Association for the Study of Diabetes (EASD)
European Foundation for the Study of Diabetes (EFSD)
Lipidomics and Nutrition Research Centre
European Federation for Clinical Chemistry and Laboratory Medicine
Spanish Society for Clinical Biochemistry and Molecular Pathology
Royal Free Hospital
Metabolic Clinic Ltd Spire Cardiff Hospital
Across the world:
International Society for the Study of Fatty Acids and Lipids (ISSFAL)
Lipid Association of India (LAI)
National Lipid Association
Philippine Lipid & Atherosclerosis Society
International Atherosclerosis Society
Endocrine Society
American Oil Chemists' Society
Canadian Cardiovascular Society
American Society for Nutrition
Biophysical Society
American Society for Biochemistry and Molecular Biology (ASBMB)
The Korean Society of Cardiology
American Skin Association
Australian Atherosclerosis Society
American Diabetes Association
Baker Heart and Diabetes Institute
British Dietetic Association
Canadian Obesity Network
Diabetes Australia
European Association for the Study of Diabetes
The Obesity Society
International Federation for the Surgery of Obesity and Metabolic Disorders
Diabetic Foot Society of India
UConn Rudd Center for Food Policy & Obesity
Stop obesity alliance
Center for Diabetes & Endocrinology
Diabetes Association of Jamaica
The Nutrition Society
The Diabetes Association of the Republic of China (Taiwan)
The Endocrine Society of the Republic of China (Taiwan)
Chinese Taipei Diabetes Association
Diabetes Australia
Diabetes Canada
Korean Diabetes Association
Diabetes Philippines
Juvenile Diabetes Research Foundation
International Diabetes Federation
The Japan Diabetes Society
Diabetes Association
Estonian Diabetes Association
Society for Endocrinology
Korean Endocrine Society
International Society of Endocrinology
The Turkish Biochemical society
International Society of Hypertension
Pediatric Endocrine Society
The American Society for Biochemistry and Molecular Biology
Australian Society Biochemistry and Molecular Biology
International Federation of Clinical Chemistry and Laboratory Medicine
American Society for Metabolism and bariatric Surgery
National Institute of Neurological Disorders and Stroke
International Association for the Study of Obesity
American Diabetes Association
International Association for the Study of Obesity
National Heart, Lung, and Blood Institute of the National Institutes of Health

Market Value on Lipids Research:

Global Nutritional Lipids Market:

International nutritional lipids market is controlled to produce at a CAGR of 13.1% from 2017 to 2022 to touch USD 7,000.7 million by 2022. This growth is endorsed to the cumulative requirement to meet nutritional requirements of an aging population, increasing the prevalence of chronic diseases, changing food landscape, increasing application in infant prescriptions and nutritive enhancements, and technological progressions such as microencapsulation. However, finite supply of fish oil and uncertain regulatory environment restricts the growth of the global nutritional lipids market to some extent.

The GPN is expected to increase from $5.69 billion to $12.19 billion from 2016 to 2023 with a CAGR of 11.4%. The lipid nutrition market is fueled by technological advancements and innovations. Recent trends of vegan food habit and supplementary diet by the urban population across the globe is expected to increase the growth of the market. Increasing health issues, awareness about the benefits of lipid nutrition, rising demand for lipid nutrition in infant formula, animal nutrition and dietary supplements and the demand to meet the nutritional requirements of an aging population are the factors propelling the market growth. However, limited supply of fish oil and environmental regulations are hindering the market growth.

The key players are:

Aker Biomarine ASA
Archer Daniels Midland Company
BASF SE
Cargill, Incorporated
Cellana Inc
Clover Corporation
Croda International Plc.
FMC Corporation
GC Rieber Oil AS
Kerry Group
Koninklijke DSM N.V
Lonza Group AG
Nordiac Naturals, Inc.
Omega Protein Corporation
Pharma Marine AS
Polaris
Smit & Zoon
Solutex GC
Stepan Company

Triglycerides- Global Market:

Global Market of Medium-Chain Triglycerides expected to reach $524.57 million to $869.95 million from 2016-2023 with a growth rate CAGR of 7.4% during the forecast period. Some of the factors such as expanding health concerns of consumers and growing number of applications are fueling the market growth. However, more number of substitutes is hampering the market. Rising demand in emer Growing usage of chemical lubricant as skin protector, especially in personal care and growing usage of caprylic/capric triglycerides in food & beverages as an ingredient are fueling the growth of caprylic/capric triglycerides market. This growth can be attributed to the increasing demand for caprylic/capric triglycerides in food & beverages, personal care, pharmaceuticals, and other industries worldwide.ging economies provides ample of opportunities for the market growth.

Medium-chain Triglycerides Market analysis based on Fatty acid Type, Form, Source, and Region is projected to reach $809.3 Million by 2022, with a growth rate CAGR of 6.1% from 2017. This analysis demands for nutritional food and increasing health awareness among customers.

Caprylic/Capric Triglycerides Market analysis by Application and Region (Asia-Pacific, Europe, North America, Latin America, and Middle East & Africa) is predictable to touch $913.4 Million by 2026, with a growth rate CAGR of 5.9% from 2016 to 2026.

Key Companies:

Wilmar International Limited
Croda International PLC.
Koninklijke DSM N.V.
Emery Oleochemicals Group
Musim Mas Holdings
Acme-Hardesty Co. Inc.
Sternchemie GmbH & Co Kg
E.I. Dupont De Nemours and Company
KLK OLEO

Global POC (point of care) Lipid testing market:

POC lipid testing is applied to quantity the lipid level of the blood at an appropriate place near the patient. The test also measures high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglyceride level of the blood. POC tests help reduce the time between the diagnosis and treatment of a disease. They are antibody-based or microbial particle-based detection methods. A healthcare professional or a nurse obtains the testing samples from a patient, performs the analysis, and records the result. The assessments comprise ELISA, agglutination tests, and lateral flow immunochromatography.

Further, the report states that one challenge in the market is rising cost of POC lipid testing. POC tests are associated with higher costs per test due to their faster TAT and consumable costs. However, normal testing of the lipid is much lower in cost. Normal testing costs around $34 and POC lipid testing costs around $150 globally.

The analysts forecast the global POC lipid testing market to grow at a CAGR of 6.28% during the period 2017-2021.

Key Companies:
Accutech
Menarini Group
Bio-Rad
Biochemical Systems International
Eurotrol
General Life Biotechnology
Helena
Nova Biomedical
Randox
Samsung
Jant Pharmacal
SD Biosensor

Lipid Panel Test Market:

Lipid panel is a board of blood assessments that helps as an initial comprehensive medical screening tool for anomalies in lipids(cholesterol and triglycerides). This test enables diagnosis of lipid disorders along with risk for coronary heart disease. There is a high correlation between coronary heart diseases (CHD) with abnormal lipid levels. These tests provide value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL. LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. The findings describes genetic diseases and can regulate approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases. Globally increasing cases of dyslipidemia, cardiovascular diseases, and hypertension is expected to drive the demand for lipid profile tests during the period of study.

Biologically North America conquered universal lipid panel test market focused by best in the class healthcare infrastructure, advanced facilities and awareness and openness amongst citizens towards the availability of the treatment and higher spending by citizens on the healthcare. North America was followed by Europe and Asia-Pacific as second and third largest market for lipid panel test market. Fastest growth can be seen in Asia Pacific, owing to rapidly increasing healthcare infrastructure and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

Key Players:

Abbott Laboratories
Alere Inc.
Avanti Polar Lipids, Inc.
Beckman Coulter, Inc.
EuroMedixPOC nv/sa
F. Hoffmann-La Roche Ltd
PTS Diagnostics
Quest Diagnostics
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.

Economic Burden of Condition/Disease in Europe:

Lipid level impact on the risk of cardiovascular disease and coronary heart disease events are economically burden. The direct and indirect costs of all types of cardiovascular disease in 2015 were estimated to be $706.2 billion. The cost of cardiovascular disease exceeds that of any other high-cost medical conditions. For example, in 2008, the estimated total cost of all cancers was $228 billion and in 2007, the cost attributable to diabetes mellitus was $174 billion.

Heart disease and stroke are not only a major cause of premature death in persons younger than 65 years but also are major causes of serious disability in the United States. The indirect costs of cardiovascular disease, including those related to lost productivity, are enormous. It is estimated that the indirect cost of cardiovascular disease will total more than $279.1 billion in 2014.

The cost of implementing a lipid screening program varies by location, provider base, method of screening, which cholesterol measurements are taken, and other factors. The average cost of a single cholesterol or lipid profile test is relatively low but the cumulative costs of screening can be substantial, especially if all recommended screening and follow-up procedures are followed. In 2008, the private-sector cost of annual visits to lower LDL cholesterol averaged $74 per session.

Estimated Cost of Counseling and Treatment:

The total cost of reducing low-density lipoprotein includes the costs of physician services, lifestyle counseling, screening, case finding and monitoring, dietary and exercise modifications, medications, and treating side effects. The annual cost of statin drugs to reduce low-density lipoprotein cholesterol levels can range from $1,082 to $1,543 per year. The cost of follow-up or treatment-related appointments varies by type of provider, location, and practice setting. Although the cost of reducing low-density lipoprotein cholesterol levels can be high, it is much lower than the direct and indirect costs of cardiovascular disease.

In 2002, the National Cholesterol Education Program (NCEP) panel found that, on the basis of current retail prices for lipid-lowering drugs, low-density lipoprotein-lowering drug therapy is highly cost-effective for persons with established coronary heart disease (including a prior coronary heart disease event); cost-effective for the primary prevention of coronary heart disease in persons with a coronary heart disease risk equivalent (the person does not have coronary heart disease but does have an absolute 10-year risk of developing major coronary events, such as myocardial infarction and coronary death, equal to that of persons with coronary heart disease), and those at high risk for coronary heart disease; and acceptable for the primary prevention of coronary heart disease in persons whose 10-year risk of "hard coronary heart disease" (heart attack and death from coronary heart disease) is between 10% and 20%.

The National Cholesterol Education Program recommends using dietary therapy, which is more cost-effective than low-density lipoprotein-lowering drugs, as the first-line therapy in persons with a 10-year risk of coronary heart disease that is less than 10% per year.

Preventive Intervention Information:

Purpose of Screening, Counseling, and Treatment:

Screening for lipid disorders allows patients and clinicians to begin lipid-lowering treatment before cardiovascular disease develops or progresses. Most patients agree to be screened for lipid disorders, even when the screening involves fasting.

Benefits and Risks of Intervention:

Clinical trials have shown that reducing low-density lipoprotein levels reduces coronary heart disease risk, but the benefits of increasing high-density lipoprotein levels have not yet been fully demonstrated. In short-term clinical trials, a 1% reduction in low-density lipoprotein cholesterol levels, on average, reduced the risk of hard coronary heart disease events by about 1%. Persons who take low-density lipoprotein cholesterol-lowering drugs for about 5 years reduce their low-density lipoprotein levels by approximately 30% and decrease their risk of cardiovascular disease, including heart attacks, by about 30%. However, only about half of those who would benefit from lipid treatment receive it.

In persons with established coronary heart disease, low-density lipoprotein-lowering therapy reduces risk of stroke by about 30%. Statin therapy for the primary and secondary prevention of cardiovascular disease can reduce adverse cardiovascular events (including heart attacks and strokes) by 32% among patients aged 65 and older. Primary prevention trials using statins have shown a significant reduction in coronary heart disease mortality, no increase in non-coronary heart disease mortality, and a strong trend toward lower overall mortality.

Target Audience:

Lipidologists
Scientists and Doctors
Healthcare Professionals
Pharmaceutical researchers
Biochemists
Clinical organizations
Educational institutes
Academic Professionals
Pharma Industries
Manufacturing Medical Devices Companies
Medical Colleges

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 01-02, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Media Partners

Association with

Testimonials

The conference was very enjoyable and academically very profitable. I enjoyed meeting so many people from so many different places. It was a perfect mix of topics, people, science and social gathering. I found the whole conference really inspiring. Thanks again for your wonderful hospitality & congratulations for the organization.
Ida Perrotta, University of Calabria, Italy

It was a very enjoyable and successful meeting in Rome and thanks for the wonderful arrangements. It was indeed my pleasure to help the organization in making this meeting a grand success. I am pleased to inform that my whole day session on Dec 11th was a great success and thanks for the superb arrangement! My Keynote address was very warmly received and I want to thank for everything.
M Raj Lakshman, VA Medical Center, USA

4^th International Conference on Lipid Science and Technology November 01-02, 2018 Valencia, Spain

Recommended Global Biochemistry Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Lipids 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Association with

Association with

Association with

Useful Links

Special Issues

Testimonials